AU7987898A - Antigenic modulation of viral particules - Google Patents

Antigenic modulation of viral particules

Info

Publication number
AU7987898A
AU7987898A AU79878/98A AU7987898A AU7987898A AU 7987898 A AU7987898 A AU 7987898A AU 79878/98 A AU79878/98 A AU 79878/98A AU 7987898 A AU7987898 A AU 7987898A AU 7987898 A AU7987898 A AU 7987898A
Authority
AU
Australia
Prior art keywords
antigenic modulation
particules
viral
viral particules
antigenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU79878/98A
Inventor
John W. Eaton
Mark D. Scott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Albany Medical College
Original Assignee
Albany Medical College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Albany Medical College filed Critical Albany Medical College
Publication of AU7987898A publication Critical patent/AU7987898A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Cell Biology (AREA)
  • Medicinal Preparation (AREA)
AU79878/98A 1997-06-26 1998-06-25 Antigenic modulation of viral particules Abandoned AU7987898A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88344797A 1997-06-26 1997-06-26
US08883447 1997-06-26
PCT/US1998/013198 WO1999000145A1 (en) 1997-06-26 1998-06-25 Antigenic modulation of viral particules

Publications (1)

Publication Number Publication Date
AU7987898A true AU7987898A (en) 1999-01-19

Family

ID=25382598

Family Applications (1)

Application Number Title Priority Date Filing Date
AU79878/98A Abandoned AU7987898A (en) 1997-06-26 1998-06-25 Antigenic modulation of viral particules

Country Status (2)

Country Link
AU (1) AU7987898A (en)
WO (1) WO1999000145A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2615637C (en) * 2006-12-22 2014-12-02 Canadian Blood Services Prevention of biofilm formation using pegylated blood products
US7964339B2 (en) * 2007-02-09 2011-06-21 Canadian Blood Services Cold storage of modified platelets
US8067151B2 (en) 2007-02-09 2011-11-29 Canadian Blood Services Cold storage of pegylated platelets at about or below 0° C.
EP2163261A1 (en) * 2008-07-14 2010-03-17 Canadian Blood Services Cold storage of PEG modified platelets
US10434070B2 (en) 2015-01-02 2019-10-08 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to enable blood transfusion

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996021036A2 (en) * 1994-12-30 1996-07-11 Chiron Viagene, Inc. Nucleic acid condensing agents with reduced immunogenicity
WO1996041606A2 (en) * 1995-06-08 1996-12-27 Therexsys Limited Improved pharmaceutical compositions for gene therapy
EP0901521B1 (en) * 1996-02-01 2005-11-02 Biomedical Frontiers, Inc. Antigenic modulation of cells
DE69800640T2 (en) * 1997-01-29 2001-07-05 Polymasc Pharmaceuticals Plc, London PEGYLATION PROCEDURE

Also Published As

Publication number Publication date
WO1999000145A9 (en) 1999-04-15
WO1999000145A1 (en) 1999-01-07

Similar Documents

Publication Publication Date Title
AU9623898A (en) Vaccines
AU6065998A (en) Influenza vaccine
AU4781297A (en) Vaccines
AU2958997A (en) Concentrated antibody preparation
AU3790497A (en) Anastomotic fitting
AU1718397A (en) Micromixer
AU1308495A (en) Influenza vaccine
AU5799098A (en) Preparation of gabapentin
AU6729198A (en) Cosmetic preparations
AU5247898A (en) Executable flowchart
AU3761297A (en) Synchronous modulator and methods for synchronous modulation
AU5122498A (en) Reusable diaper
AU5270598A (en) Single sideband modulators
AU6266798A (en) Disposable multi-sampler and fitment
AU1555297A (en) Antigenic modulation of cells
AU6928098A (en) Optical modulator
AU4944297A (en) Modulation of apoptosis
AU9303698A (en) Anastomotic coupler
AU7290898A (en) Preparation of fagopyritols and uses therefor
AUPO026596A0 (en) Viral peptide
AU7987898A (en) Antigenic modulation of viral particules
AU1887297A (en) Optical modulator
AU1233399A (en) Colorant preparations
AUPO790997A0 (en) Modulated solid state spectrometer
AU2539697A (en) Anti-idiotypic antibody vaccines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase